BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26015570)

  • 1. Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy.
    Barrett CL; DeBoever C; Jepsen K; Saenz CC; Carson DA; Frazer KA
    Proc Natl Acad Sci U S A; 2015 Jun; 112(23):E3050-7. PubMed ID: 26015570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verifying the markers of ovarian cancer using RNA-seq data.
    Liu T; Yu N; Ding F; Wang S; Li S; Zhang X; Sun X; Chen Y; Liu P
    Mol Med Rep; 2015 Jul; 12(1):1125-30. PubMed ID: 25776533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of alternately spliced messenger RNA of the luteinizing hormone receptor and stability of the follicle-stimulating hormone receptor messenger RNA in granulosa cell tumors of the human ovary.
    Reinholz MM; Zschunke MA; Roche PC
    Gynecol Oncol; 2000 Nov; 79(2):264-71. PubMed ID: 11063655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA sequencing (RNA-Seq) and its application in ovarian cancer.
    Wang J; Dean DC; Hornicek FJ; Shi H; Duan Z
    Gynecol Oncol; 2019 Jan; 152(1):194-201. PubMed ID: 30297273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the transcriptome space of a recombinant BHK cell line through next generation sequencing.
    Johnson KC; Yongky A; Vishwanathan N; Jacob NM; Jayapal KP; Goudar CT; Karypis G; Hu WS
    Biotechnol Bioeng; 2014 Apr; 111(4):770-81. PubMed ID: 24249083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq.
    Li P; Conley A; Zhang H; Kim HL
    BMC Genomics; 2014 Dec; 15(1):1087. PubMed ID: 25495041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators.
    Moyle-Heyrman G; Schipma MJ; Dean M; Davis DA; Burdette JE
    J Ovarian Res; 2016 Feb; 9():5. PubMed ID: 26879975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.
    Darb-Esfahani S; Kunze CA; Kulbe H; Sehouli J; Wienert S; Lindner J; Budczies J; Bockmayr M; Dietel M; Denkert C; Braicu I; Jöhrens K
    Oncotarget; 2016 Jan; 7(2):1486-99. PubMed ID: 26625204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of EVI1 and EVI1s (Delta324) as potential therapeutic targets in ovarian cancer.
    Jazaeri AA; Ferriss JS; Bryant JL; Dalton MS; Dutta A
    Gynecol Oncol; 2010 Aug; 118(2):189-95. PubMed ID: 20462630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.
    Thériault BL; Pajovic S; Bernardini MQ; Shaw PA; Gallie BL
    Int J Cancer; 2012 Apr; 130(8):1844-54. PubMed ID: 21618518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-Seq reveals differentially expressed isoforms and novel splice variants in buccal mucosal cancer.
    Jakhesara SJ; Koringa PG; Bhatt VD; Shah TM; Vangipuram S; Shah S; Joshi CG
    Gene; 2013 Mar; 516(1):24-32. PubMed ID: 23266631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
    Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.
    Bösmüller H; Fischer A; Pham DL; Fehm T; Capper D; von Deimling A; Bonzheim I; Staebler A; Fend F
    Hum Pathol; 2013 Mar; 44(3):329-35. PubMed ID: 23089489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative transcriptome analysis of epithelial and fiber cells in newborn mouse lenses with RNA sequencing.
    Hoang TV; Kumar PK; Sutharzan S; Tsonis PA; Liang C; Robinson ML
    Mol Vis; 2014; 20():1491-517. PubMed ID: 25489224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
    Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell transcriptome analysis of endometrial tissue.
    Krjutškov K; Katayama S; Saare M; Vera-Rodriguez M; Lubenets D; Samuel K; Laisk-Podar T; Teder H; Einarsdottir E; Salumets A; Kere J
    Hum Reprod; 2016 Apr; 31(4):844-53. PubMed ID: 26874359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum-Taxane Chemotherapy.
    Chen P; Huhtinen K; Kaipio K; Mikkonen P; Aittomäki V; Lindell R; Hynninen J; Auranen A; Grénman S; Lehtonen R; Carpén O; Hautaniemi S
    Cancer Res; 2015 Aug; 75(15):2987-98. PubMed ID: 26122843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput RNA-seq for allelic or locus-specific expression analysis in Arabidopsis-related species, hybrids, and allotetraploids.
    Ng DW; Shi X; Nah G; Chen ZJ
    Methods Mol Biol; 2014; 1112():33-48. PubMed ID: 24478006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.
    Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2009 Jul; 48(7):648-61. PubMed ID: 19123201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.